Vaxcyte (PCVX) Cash & Current Investments (2019 - 2026)
Vaxcyte (PCVX) reported Cash & Current Investments of $1.49 billion for Q2 2026, down 10.5% from $1.66 billion a year earlier and down 14.4% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Cash & Current Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Vaxcyte posted Cash & Current Investments of $1.56 billion, down 10.7% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of 32.2% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $1.75 billion in FY2024 (+61.7%), $1.08 billion in FY2023 (+16.0%), $931.38 million in FY2022 (+278.7%) and $245.97 million in FY2021 (-36.3%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q2 2024.
- Year over year, Cash & Current Investments gained in five of the last eight quarters, with growth averaging 15.3%.
- The high point for year-over-year Cash & Current Investments in five years was Q4 2022 (growth of 278.7%); the low point was Q4 2021 (a decline of 36.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.74 billion (Q1 2026), $1.56 billion (Q4 2025) and $1.71 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Vaxcyte | 9.07 Bn | 2.57 Bn | - | 1.49 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Bn |
| Mar 31, 2026 | 1.74 Bn |
| Dec 31, 2025 | 1.56 Bn |
| Sep 30, 2025 | 1.71 Bn |
| Jun 30, 2025 | 1.66 Bn |
| Mar 31, 2025 | 1.67 Bn |
| Dec 31, 2024 | 1.75 Bn |
| Sep 30, 2024 | 2.18 Bn |
| Jun 30, 2024 | 1.45 Bn |
| Mar 31, 2024 | 1.49 Bn |
| Dec 31, 2023 | 1.08 Bn |
| Sep 30, 2023 | 1.27 Bn |
| Jun 30, 2023 | 1.29 Bn |
| Mar 31, 2023 | 822.04 Mn |
| Dec 31, 2022 | 931.38 Mn |
| Sep 30, 2022 | 362.23 Mn |
| Jun 30, 2022 | 354.50 Mn |
| Mar 31, 2022 | 334.64 Mn |
| Dec 31, 2021 | 245.97 Mn |
| Sep 30, 2021 | 278.58 Mn |
API Access
Vaxcyte Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();